Francesca Rotondo
University of Bologna
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Francesca Rotondo.
Toxicology in Vitro | 2010
Maria Grazia Mascolo; Stefania Perdichizzi; Francesca Rotondo; Elena Morandi; Angela Guerrini; Paola Silingardi; Monica Vaccari; Sandro Grilli; Annamaria Colacci
The prediction of the carcinogenic risk for humans is mostly based on animal experiments. For the last 20 years, however, the scientific community has paid great attention to alternative strategies in compliance with common moral and ethical values. The new European chemical regulation REACH (Reg. EC 1907/2006) requires the performance of new studies in vertebrates only as a last resort. REACH asks for the development of validated in vitro protocols that can replace, in the medium to the long term, animal bioassays. An in vitro cell transformation assay (CTA) is proposed as an alternative to in vivo carcinogenicity testing. This assay is reported in the list of accepted methods for REACH (Reg. EC 440/2008). The BALB/c 3T3 model represents one of the most well-known CTAs and is regarded as a useful tool to screen single chemicals or complex mixtures for carcinogenicity prediction. In this study we used a modified protocol to highlight the transforming potential of three single compounds, ethinylestradiol (EE), azathioprine (AZA-T), melphalan, and two polychlorinated biphenyls (PCBs) mixtures, which are known or suspected to be human carcinogens. We also evaluated the activity of the antioxidant alpha-lipoic acid (ALA), a promising tumor chemopreventive. A significant increase in transformation frequency was observed when the BALB/c 3T3 cells were exposed to EE, AZA-T or melphalan as well as after PCBs treatment. On the contrary, ALA did not induce any increase of foci occurrence. Our results confirm the suitability of the improved protocol to discriminate carcinogenic compounds and support the use of BALB/c 3T3 cell transformation assay as a possible alternative to predict carcinogenic risk to humans.
Toxicology in Vitro | 2015
Monica Vaccari; Maria Grazia Mascolo; Francesca Rotondo; Elena Morandi; Daniele Quercioli; Stefania Perdichizzi; Cristina Zanzi; Stefania Serra; Vanes Poluzzi; Paola Angelini; Sandro Grilli; Annamaria Colacci
The particulate matter represents one of the most complex environmental mixtures, whose effects on human health and environment vary according to particles characteristics and source of emissions. The present study describes an integrated approach, including in vitro tests and toxicogenomics, to highlight the effects of air particulate matter on toxicological relevant endpoints. Air samples (PM2.5) were collected in summer and winter at different sites, representative of different levels of air pollution. Samples organic extracts were tested in the BALB/c 3T3 CTA at a dose range 1-12m(3). The effect of the exposure to the samples at a dose of 8m(3) on the whole-genome transcriptomic profile was also assessed. All the collected samples induced dose-related toxic effects in the exposed cells. The modulated gene pathways confirmed that toxicity was related to sampling season and sampling site. The analysis of the KEGGs pathways showed modulation of several gene networks related to oxidative stress and inflammation. Even if the samples did not induce cell transformation in the treated cells, gene pathways related to the onset of cancer were modulated as a consequence of the exposure. This integrated approach could provide valuable information for predicting toxic risks in humans exposed to air pollution.
Toxicology in Vitro | 2014
Stefania Perdichizzi; Maria Grazia Mascolo; Paola Silingardi; Elena Morandi; Francesca Rotondo; Angela Guerrini; Luciana Prete; Monica Vaccari; Annamaria Colacci
Penconazole is a systemic triazole fungicide mainly used on grapes. The UE Maximum Residue Level (MRL) for penconazole is set at 0.2ppm in wine and grapes. In the aim of identifying potential biomarkers of exposure to penconazole and possibly highlighting its endocrine disrupting mode of action, we used a transcriptomics-based approach to detect genes, that are transcriptionally modulated by penconazole, by using an appropriate in vitro model. T-47D cells were treated with commercial penconazole or penconazole contaminated grape extracts for 4h at doses close to the MRL. The whole-genome transcriptomic profile was assessed by using genome 44K oligo-microarray slides. The list of common genes generated by the two treatments could be representative of potential markers of exposure. In order to understand the role of these genes in key events related to adversity, a pathway analysis was performed on a list of genes with the same modulation trend (up or down). The analysis returned a set of genes involved in Thyroid Cancer Pathway, thus confirming a role of penconazole in endocrine disrupting mediated effects and strongly suggesting a possible mode of action in thyroid carcinogenesis.
Toxicology in Vitro | 2011
Annamaria Colacci; Maria Grazia Mascolo; Stefania Perdichizzi; Daniele Quercioli; Antonio Gazzilli; Francesca Rotondo; Elena Morandi; Angela Guerrini; Paola Silingardi; Sandro Grilli; Monica Vaccari
Cell transformation assays (CTAs) are currently regarded as the only possible in vitro alternative to animal testing for carcinogenesis studies. CTAs have been proposed as screening tests for the carcinogenic potential of compounds that have no evidence of genotoxicity but present structural alerts for carcinogenicity. We have extensively used the BALB/c 3T3 model based on the A31 cell clone to test single chemicals, complex mixtures and environmental pollutants. In the prevalidation study carried out by ECVAM, the improved protocol is based on BALB/c 3T3 A31-1-1 cells, a clone derived by A31 cells, that is very sensitive to PAH-induced transformation. The present study was performed in the aim to compare the results obtained with the two different clones exposed to different classes of carcinogens. Cells were treated with PAHs (3-methylcholanthrene, benzo(a)pyrene), alkylating agents (melphalan) and aloethanes (1,2-dibromoethane). The induction of cytotoxicity and the onset of chemically transformed foci were evaluated by two experimental protocols, differing for cell seeding density and chemical treatment duration. The A31-1-1 cells showed higher inherent transformation rate after PAHs treatment, but they were insensitive to 1,2-dibromoethane at concentrations that usually induced transformation in A31 cells. As 1,2-dibromoethane is bioactivated to reactive forms able to bind DNA mainly through the conjugation with intracellular glutathione, these results suggested a reduced activity of phase-2 enzymes involved in glutathione conjugation in A31-1-1 cells. Our results give evidence that inherent metabolic capacity of cells may play a critical role in in vitro cell transformation, cautioning against possible misclassification of chemicals.
Carcinogenesis | 2018
Maria Grazia Mascolo; Stefania Perdichizzi; Monica Vaccari; Francesca Rotondo; Cristina Zanzi; Sandro Grilli; Martin Paparella; Miriam N. Jacobs; Annamaria Colacci
The development of alternative methods to animal testing is a priority in the context of regulatory toxicology. Carcinogenesis is a field where the demand for alternative methods is particularly high. The standard rodent carcinogenicity bioassay requires a large use of animals, high costs, prolonged duration and shows several limitations, which can affect the comprehension of the human relevance of animal carcinogenesis. The cell transformation assay (CTA) has long been debated as a possible in vitro test to study carcinogenesis. This assay provides an easily detectable endpoint of oncotransformation, which can be used to anchor the exposure to the acquisition of the malignant phenotype. However, the current protocols do not provide information on either molecular key events supporting the carcinogenesis process, nor the mechanism of action of the test chemicals. In order to improve the use of this assay in the integrated testing strategy for carcinogenesis, we developed the transformics method, which combines the CTA and transcriptomics, to highlight the molecular steps leading to in vitro malignant transformation. We studied 3-methylcholanthrene (3-MCA), a genotoxic chemical able to induce in vitro cell transformation, at both transforming and subtransforming concentrations in BALB/c 3T3 cells and evaluated the gene modulation at critical steps of the experimental protocol. The results gave evidence for the potential key role of the immune system and the possible involvement of the aryl hydrocarbon receptor (AhR) pathway as the initial steps of the in vitro transformation process induced by 3-MCA, suggesting that the initiating events are related to non-genotoxic mechanisms.
Sustainability | 2014
Annamaria Colacci; Monica Vaccari; Maria Grazia Mascolo; Francesca Rotondo; Elena Morandi; Daniele Quercioli; Stefania Perdichizzi; Cristina Zanzi; Stefania Serra; Vanes Poluzzi; Paola Angelini; Sandro Grilli; Franco Zinoni
Microchemical Journal | 2018
Daniele Quercioli; Andrea Roli; Elena Morandi; Stefania Perdichizzi; Laura Polacchini; Francesca Rotondo; Monica Vaccari; Marco Villani; Roberto Serra; Annamaria Colacci
Toxicology Letters | 2007
Annamaria Colacci; Monica Vaccari; Paola Silingardi; Wolfango Horn; Maria Grazia Mascolo; Stefania Perdichizzi; Francesca Rotondo; Vanes Poluzzi; Vito Belladonna; Sandro Grilli
Toxicology Letters | 2013
Monica Vaccari; Stefania Perdichizzi; Maria Grazia Mascolo; Paola Silingardi; Elena Morandi; Francesca Rotondo; Angela Guerrini; Cecila Bergamini; Annamaria Colacci
Toxicology Letters | 2009
Francesca Rotondo; Annamaria Colacci; Paola Silingardi; MariaGrazia Mascolo; Elena Morandi; Stefania Perdichizzi; Sandro Grilli; Roberto Serra; Monica Vaccari